cas 552-70-5|| where to buy 9-methyl-9-azabicyclo[3.3.1]nonan-3-one

製品名:9-methyl-9-azabicyclo[3.3.1]nonan-3-one

IUPAC Name:9-methyl-9-azabicyclo[3.3.1]nonan-3-one

包装単位	有効在庫	価格（USD）
CM108204-5g	in stock	ȀƄ
CM108204-10g	in stock	ȎƄư
CM108204-25g	in stock	ưȀĽ

研究開発用専用.

問い合わせフォーム

化学物質名

CAS番号

数量*

要求仕様*
（アッセイ %、材料グレード等）

お名前*

連絡先Eメールアドレス*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 552-70-5 regularly via the above email.

追記事項

Verification code*

refresh

: CAS番号:552-70-5; 分子式:C9H15NO; 融点:-; SMILESコード:O=C1CC(N2C)CCCC2C1; 密度:

: カタログ番号:CM108204; 分子量:153.23; 沸点:246.7°C at 760 mmHg; MDL番号:MFCD00078161; 保管方法:Store at 2-8°C.

: Piperidines; Piperidine is an azacycloalkane that is cyclohexane in which one of the carbons is replaced by a nitrogen. Although piperidine is a common organic compound, it is an immensely important class of compounds medicinally: the piperidine ring is the most common heterocyclic subunit among FDA approved drugs.; Piperidine,Piperidine Price; if you want to know the latest news about piperidine and piperidine price, please come to our website and get a quote for free.

: Bridged Compounds; Bridged ring compound refers to any two rings in the compound, which share two non-directly connected carbon atoms, and are classified into bicyclic hydrocarbons, tricyclic hydrocarbons, tetracyclic hydrocarbons, etc. Carbon atoms used in two or more rings are bridgehead carbon atoms, and the bond connecting the bridgehead carbon atoms is called a bridge. Bridged ring compounds are a class of organic compounds that are widely present in nature and usually have important physiological activities, such as the famous anticancer drug paclitaxel and antimalarial drug artemisinin.; bridged compounds,bridged bicyclic compounds; Buy low price, high quality bridged compounds and bridged bicyclic compounds,choose our products,Chemenu is the leading factory & company. Warmly welcome new and old customers to visit and patronize!

: Sunobinop; Sunobinop is an investigational, novel and potential first-in-class oral compound discovered by Imbrium Therapeutics and that is currently in clinical development. Sunobinop is designed to bind to and activate the nociceptin/orphanin-FQ peptide receptor (NOP), a protein that is widely expressed in the central and peripheral nervous system and involved in a range of biological functions, including bladder function.
As of Feb 2024, it is under clinical investigation for the treatment of insomnia/alcohol use disorder, interstitial cystitis, and overactive bladder syndrome. It was previously also under investigation for the treatment of fibromyalgia.